IBDEI0KP ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27986,0)
 ;;=369.12^^155^1749^82
 ;;^UTILITY(U,$J,358.3,27986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27986,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,27986,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,27986,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,27987,0)
 ;;=369.13^^155^1749^80
 ;;^UTILITY(U,$J,358.3,27987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27987,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,27987,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,27987,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,27988,0)
 ;;=369.14^^155^1749^81
 ;;^UTILITY(U,$J,358.3,27988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27988,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,27988,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,27988,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,27989,0)
 ;;=369.22^^155^1749^102
 ;;^UTILITY(U,$J,358.3,27989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27989,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,27989,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,27989,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,27990,0)
 ;;=369.60^^155^1749^6
 ;;^UTILITY(U,$J,358.3,27990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27990,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,27990,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,27990,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,27991,0)
 ;;=369.9^^155^1749^115
 ;;^UTILITY(U,$J,358.3,27991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27991,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,27991,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,27991,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,27992,0)
 ;;=377.61^^155^1749^20
 ;;^UTILITY(U,$J,358.3,27992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27992,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,27992,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,27992,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,27993,0)
 ;;=379.02^^155^1749^68
 ;;^UTILITY(U,$J,358.3,27993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27993,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,27993,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,27993,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,27994,0)
 ;;=379.07^^155^1749^90
 ;;^UTILITY(U,$J,358.3,27994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27994,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,27994,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,27994,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,27995,0)
 ;;=379.92^^155^1749^106
 ;;^UTILITY(U,$J,358.3,27995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27995,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,27995,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,27995,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,27996,0)
 ;;=379.93^^155^1749^94
 ;;^UTILITY(U,$J,358.3,27996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27996,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,27996,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,27996,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,27997,0)
 ;;=379.99^^155^1749^86
 ;;^UTILITY(U,$J,358.3,27997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27997,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,27997,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,27997,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,27998,0)
 ;;=555.9^^155^1749^95
 ;;^UTILITY(U,$J,358.3,27998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27998,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,27998,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,27998,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,27999,0)
 ;;=696.1^^155^1749^93
 ;;^UTILITY(U,$J,358.3,27999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27999,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,27999,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,27999,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,28000,0)
 ;;=709.2^^155^1749^39
 ;;^UTILITY(U,$J,358.3,28000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28000,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,28000,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,28000,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,28001,0)
 ;;=710.0^^155^1749^60
 ;;^UTILITY(U,$J,358.3,28001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28001,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,28001,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,28001,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,28002,0)
 ;;=710.9^^155^1749^10
 ;;^UTILITY(U,$J,358.3,28002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28002,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,28002,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,28002,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,28003,0)
 ;;=714.0^^155^1749^98
 ;;^UTILITY(U,$J,358.3,28003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28003,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,28003,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,28003,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,28004,0)
 ;;=714.30^^155^1749^99
 ;;^UTILITY(U,$J,358.3,28004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28004,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,28004,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,28004,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,28005,0)
 ;;=744.89^^155^1749^38
 ;;^UTILITY(U,$J,358.3,28005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28005,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,28005,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,28005,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,28006,0)
 ;;=759.6^^155^1749^116
 ;;^UTILITY(U,$J,358.3,28006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28006,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,28006,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,28006,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,28007,0)
 ;;=759.82^^155^1749^62
 ;;^UTILITY(U,$J,358.3,28007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28007,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,28007,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,28007,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,28008,0)
 ;;=802.4^^155^1749^36
 ;;^UTILITY(U,$J,358.3,28008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28008,1,3,0)
 ;;=3^FX Malar/Maxillary Bones,Closed
 ;;^UTILITY(U,$J,358.3,28008,1,4,0)
 ;;=4^802.4
 ;;^UTILITY(U,$J,358.3,28008,2)
 ;;=^25312
 ;;^UTILITY(U,$J,358.3,28009,0)
 ;;=870.1^^155^1749^53
 ;;^UTILITY(U,$J,358.3,28009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28009,1,3,0)
 ;;=3^Laceration Full Thickness
 ;;^UTILITY(U,$J,358.3,28009,1,4,0)
 ;;=4^870.1
 ;;^UTILITY(U,$J,358.3,28009,2)
 ;;=^274880
 ;;^UTILITY(U,$J,358.3,28010,0)
 ;;=870.2^^155^1749^34
 ;;^UTILITY(U,$J,358.3,28010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28010,1,3,0)
 ;;=3^Eyelid Laceration Involving Lacrimal
 ;;^UTILITY(U,$J,358.3,28010,1,4,0)
 ;;=4^870.2
 ;;^UTILITY(U,$J,358.3,28010,2)
 ;;=^274881
 ;;^UTILITY(U,$J,358.3,28011,0)
 ;;=870.3^^155^1749^84
 ;;^UTILITY(U,$J,358.3,28011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28011,1,3,0)
 ;;=3^Orbital Wound,Penetrating
 ;;^UTILITY(U,$J,358.3,28011,1,4,0)
 ;;=4^870.3
 ;;^UTILITY(U,$J,358.3,28011,2)
 ;;=^274882
 ;;^UTILITY(U,$J,358.3,28012,0)
 ;;=870.9^^155^1749^69
 ;;^UTILITY(U,$J,358.3,28012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28012,1,3,0)
 ;;=3^Ocular Adnexa Open Wound,Unspec
 ;;^UTILITY(U,$J,358.3,28012,1,4,0)
 ;;=4^870.9
 ;;^UTILITY(U,$J,358.3,28012,2)
 ;;=^274885
 ;;^UTILITY(U,$J,358.3,28013,0)
 ;;=871.0^^155^1749^70
 ;;^UTILITY(U,$J,358.3,28013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28013,1,3,0)
 ;;=3^Ocular Laceration
 ;;^UTILITY(U,$J,358.3,28013,1,4,0)
 ;;=4^871.0
 ;;^UTILITY(U,$J,358.3,28013,2)
 ;;=^274886
 ;;^UTILITY(U,$J,358.3,28014,0)
 ;;=871.1^^155^1749^71
 ;;^UTILITY(U,$J,358.3,28014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28014,1,3,0)
 ;;=3^Ocular Laceration w/ Prolapse
 ;;^UTILITY(U,$J,358.3,28014,1,4,0)
 ;;=4^871.1
 ;;^UTILITY(U,$J,358.3,28014,2)
 ;;=^274887
 ;;^UTILITY(U,$J,358.3,28015,0)
 ;;=871.2^^155^1749^100
 ;;^UTILITY(U,$J,358.3,28015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28015,1,3,0)
 ;;=3^Rupture Eye,Trauma Enuc
 ;;^UTILITY(U,$J,358.3,28015,1,4,0)
 ;;=4^871.2
 ;;^UTILITY(U,$J,358.3,28015,2)
 ;;=^274888
 ;;^UTILITY(U,$J,358.3,28016,0)
 ;;=871.6^^155^1749^59
 ;;^UTILITY(U,$J,358.3,28016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28016,1,3,0)
 ;;=3^Lens,Penetration w/ FB
 ;;^UTILITY(U,$J,358.3,28016,1,4,0)
 ;;=4^871.6
 ;;^UTILITY(U,$J,358.3,28016,2)
 ;;=^274891
 ;;^UTILITY(U,$J,358.3,28017,0)
 ;;=871.7^^155^1749^72
 ;;^UTILITY(U,$J,358.3,28017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28017,1,3,0)
 ;;=3^Ocular Penetration,Unspec
 ;;^UTILITY(U,$J,358.3,28017,1,4,0)
 ;;=4^871.7
 ;;^UTILITY(U,$J,358.3,28017,2)
 ;;=^274892
 ;;^UTILITY(U,$J,358.3,28018,0)
 ;;=871.9^^155^1749^9
 ;;^UTILITY(U,$J,358.3,28018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28018,1,3,0)
 ;;=3^Ciliary Body,Open Wound
 ;;^UTILITY(U,$J,358.3,28018,1,4,0)
 ;;=4^871.9
 ;;^UTILITY(U,$J,358.3,28018,2)
 ;;=^274893
 ;;^UTILITY(U,$J,358.3,28019,0)
 ;;=907.2^^155^1749^56
 ;;^UTILITY(U,$J,358.3,28019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28019,1,3,0)
 ;;=3^Late Eff Spinal Cord Injury
 ;;^UTILITY(U,$J,358.3,28019,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,28019,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,28020,0)
 ;;=909.5^^155^1749^57
 ;;^UTILITY(U,$J,358.3,28020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28020,1,3,0)
 ;;=3^Late or Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,28020,1,4,0)
 ;;=4^909.5
 ;;^UTILITY(U,$J,358.3,28020,2)
 ;;=^303353
 ;;^UTILITY(U,$J,358.3,28021,0)
 ;;=918.0^^155^1749^105
 ;;^UTILITY(U,$J,358.3,28021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28021,1,3,0)
 ;;=3^Superfic Inj,Eyelids/Periocular
 ;;^UTILITY(U,$J,358.3,28021,1,4,0)
 ;;=4^918.0
 ;;^UTILITY(U,$J,358.3,28021,2)
 ;;=^275352
 ;;^UTILITY(U,$J,358.3,28022,0)
 ;;=918.2^^155^1749^104
 ;;^UTILITY(U,$J,358.3,28022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28022,1,3,0)
 ;;=3^Superfic Inj,Conjunctiva
 ;;^UTILITY(U,$J,358.3,28022,1,4,0)
 ;;=4^918.2
